Literature DB >> 6189637

Variations in amylase isoenzymes and lipase during acute pancreatitis, and in other disorders causing hyperamylasemia.

P Leclerc, J C Forest.   

Abstract

We compare the clinical value of assay of amylase (EC 3.2.1.1) isoenzymes with that of lipase (EC 3.1.1.3) in serum from patients with proven acute pancreatitis or with hyperamylasemia from other causes. In the former group we measured amylase, lipase, and isoamylases daily. Lipase and P(pancreas)-type isoamylases reached the highest mean values on the first day of an attack of acute pancreatitis (day one). Lipase declined rapidly, and by day four its mean activity was about the same as that of amylase and lower than that of the P-type isoamylases. Great inter-individual variations were found among patients with a similar clinical course. Of the 85 samples analyzed, amylase activity for 36 declined to within reference limits, but 18 of the 36 had high lipase activity, 18 had high P-type isoamylases activity, and 31 had P3 isoenzyme, which is not detectable in normal sera. Determination of isoamylases is a more sensitive index to acute pancreatitis than lipase assay and may be particularly useful when pancreatitis is suspected despite a normal total amylase activity. In the group of patients with hyperamylasemia from other origins, three had macroamylasemia, one had mumps, one had abdominal trauma without pancreatic injury, and one had pelvic inflammatory disease. The specific pattern of macroamylase on electrophoresis permitted a precise diagnosis of macroamylasemia; normal lipase had only ruled out pancreatitis. In the three other cases, lipase and isoamylases excluded pancreatic involvement.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6189637

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  9 in total

1.  Isoamylase determination by isoelectric focusing in pancreatic disorders. A potential clinical aid.

Authors:  G Chiarioni; B Vaona; L Benini; G Dimitri; C Scattolini; L A Scuro; I Vantini
Journal:  Int J Pancreatol       Date:  1991-01

2.  Acute pancreatitis with normal amylase.

Authors:  D B Evans; A W Robinson; R J Pettit
Journal:  Dig Dis Sci       Date:  1986-07       Impact factor: 3.199

3.  Serum elastase 1 in inflammatory pancreatic and gastrointestinal diseases and in renal insufficiency. A comparison with other serum pancreatic enzymes.

Authors:  P Malfertheiner; M Büchler; A Stanescu; W Uhl; H Ditschuneit
Journal:  Int J Pancreatol       Date:  1987-06

Review 4.  Laboratory tests in the diagnosis of the chronic pancreatic diseases. Part 4. Tests involving the measurement of pancreatic enzymes in body fluid.

Authors:  E J Boyd; H Rinderknecht; K G Wormsley
Journal:  Int J Pancreatol       Date:  1988 Jan-Feb

Review 5.  Serum amylase and lipase and urinary trypsinogen and amylase for diagnosis of acute pancreatitis.

Authors:  Gianluca Rompianesi; Angus Hann; Oluyemi Komolafe; Stephen P Pereira; Brian R Davidson; Kurinchi Selvan Gurusamy
Journal:  Cochrane Database Syst Rev       Date:  2017-04-21

6.  Frequency of pancreatitis in fulminant hepatic failure using isoenzyme markers.

Authors:  R J Ede; K P Moore; W J Marshall; R Williams
Journal:  Gut       Date:  1988-06       Impact factor: 23.059

7.  Use of amylase isoenzymes in laboratory evaluation of hyperamylasemia.

Authors:  D M Jensen; V L Royse; J N Bonello; J Schaffner
Journal:  Dig Dis Sci       Date:  1987-06       Impact factor: 3.199

8.  JPN Guidelines for the management of acute pancreatitis: diagnostic criteria for acute pancreatitis.

Authors:  Masaru Koizumi; Tadahiro Takada; Yoshifumi Kawarada; Koichi Hirata; Toshihiko Mayumi; Masahiro Yoshida; Miho Sekimoto; Masahiko Hirota; Yasutoshi Kimura; Kazunori Takeda; Shuji Isaji; Makoto Otsuki; Seiki Matsuno
Journal:  J Hepatobiliary Pancreat Surg       Date:  2006

9.  Serum pancreatic enzymes and imaging in paediatric acute pancreatitis: Does lipase diagnostic superiority justify eliminating amylase testing?

Authors:  Mohammed H AlEdreesi; Mohammed B AlAwamy
Journal:  Saudi J Gastroenterol       Date:  2022 Mar-Apr       Impact factor: 2.485

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.